Clinical Trials Index
Kidney Transplantation
Mixed Chimerism
and Renal Allografting with Non-Myeloablative Conditioning
in Patients with End-Stage Renal Failure due to Multiple
Myeloma
Principal Investigator: Megan Sykes, Massachusetts
General Hospital, Boston, MA
Renal allograft
tolerance through mixed chimerism
Principal Investigators: David Sachs, Massachusetts
General Hospital, Boston, MA; A. Benedict Cosimi,
Massachusetts General Hospital, Boston, MA
Campath-1H/Rapamycin
in Renal Transplantation
Principal Investigator: Stuart Knechtle, University
of Wisconsin Medical School, Madison, WI
A Pilot Trial of LEA29Y to Facilitate Drug Withdrawal in Renal Transplantation
Principal Investigator: Flavio Vincenti, University of California, San Francisco
Pilot Study Using Donor Stem Cells and Campath-1H To Induce Renal Transplant Tolerance
Principal Investigator: Joshua Miller, University of Miami
Liver Transplantation
Campath 1H induction therapy and immunosuppression withdrawal in liver transplant recipients
Principal Investigator: J. Richard Thistlethwaite, University of Chicago
Immunosuppression withdrawal in liver transplant recipients infected with the hepatitis C virus
Principal Investigator: Abraham Shaked, University of Pennsylvania, Philidelphia, PA
Immunosuppression Withdrawal for Stable Pediatric Living Donor Liver Transplant Recipients
Principal Investigator: Sandy Feng, University of California, San Francisco, CA
overview |
leadership | publications
